Ironwood Pharmaceuticals, Inc.
NASDAQ:IRWD
4.66 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Ironwood Pharmaceuticals, Inc. |
Symbool | IRWD |
Munteenheid | USD |
Prijs | 4.66 |
Beurswaarde | 744,383,740 |
Dividendpercentage | 0% |
52-weken bereik | 3.79 - 15.7 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Thomas A. McCourt |
Website | https://www.ironwoodpharma.com |
An error occurred while fetching data.
Over Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)